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Purpose: This study tested whether controlled drying of the cornea increases vector absorption in mouse and rabbit corneas
in vivo and human cornea ex vivo, and studied the effects of corneal drying on gene transfer, structure and inflammatory
reaction in the mouse cornea in vivo.
Methods: Female C57 black mice and New Zealand White rabbits were used for in vivo studies. Donor human corneas
were used for ex vivo experiments. A hair dryer was used for drying the corneas after removing corneal epithelium by
gentle scraping. The corneas received no, once, twice, thrice, or five times warm air for 10 s with a 5 s interval after each
10 s hair dryer application. Thereafter, balanced salt solution (BSS) was topically applied immediately on the cornea for
2 min using a custom-cloning cylinder. The absorbed BSS was quantified using Hamilton microsyringes. The adeno-
associated virus 8 (AAV8) vector (1.1×108 genomic copies/µl) expressing marker gene was used to study the effect of
corneal drying on gene transfer. Animals were sacrificed on day 14 and gene expression was analyzed using commercial
staining kit. Morphological changes and infiltration of inflammatory cells were examined with H & E staining and
immunocytochemistry.
Results: Mice, rabbit or human corneas subjected to no or 10 s drying showed 6%–8% BSS absorption whereas 20, 30,
or 50 s corneal drying showed significantly high 14%–19% (p<0.001), 21%–22% (p<0.001), and 25%–27% (p<0.001)
BSS absorption, respectively. The AAV8 application on mouse cornea after 50 s drying showed significantly higher
transgene delivery (p<0.05) in vivo with mild-to-moderate changes in corneal morphology. The 30 s of  drying also
showed significantly (p<0.05) high transgene delivery in mouse stroma in vivo without jeopardizing corneal morphology
whereas 10 or 20 s drying showed moderate degree of gene transfer with no altered corneal morphology. Corneas that
underwent 50 s drying showed high CD11b-positive cells (p<0.01) compared to control corneas whereas 20 or 30 s air-
dried corneas showed insignificant CD11b-positive cells compared to control corneas.
Conclusions: Controlled corneal drying with hair dryer increases vector absorption significantly. The dispensing of
efficacious AAV serotype into cornea with optimized minimally invasive topical application technique could provide high
and targeted expression of therapeutic genes in the stroma in vivo without causing significant side effects.
Gene therapy is an attractive approach to treat ocular
diseases. Preclinical corneal gene therapy studies in animal
models  have  shown  promising  results  [1-5].  Nonetheless,
untargeted and uncontrolled gene delivery remains a major
challenge. The clinical application of gene therapy for corneal
diseases is contingent on delivery of the therapeutic genes in
a tissue selective manner. Our central hypothesis is that vector
and vector-delivery techniques regulate transgene delivery in
the cornea, and a suitable combination of efficacious vector
and  vector-delivery  technique  can  successfully  deliver
therapeutic genes into keratocytes or stroma of the cornea in
vivo. Among various gene transfer vectors tested for corneal
gene therapy, viral vectors have emerged as favored vectors
as  they  exhibited  high  transgene  expression  for  longer
duration  [5-7].  We  found  adeno-associated  virus  (AAV)
vectors to be highly efficient and safe for delivering foreign
genes in rodent, rabbit, equine and human cornea in vitro and
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in vivo [5,6,8-11]. A varied degree of tissue selective tropism
among AAV serotypes has also been observed for the cornea
like other tissues [9-12]. The AAV serotypes 5, 8, and 9
showed  superior  transduction  efficiency  for  transporting
genes in the rodent or rabbit cornea in vivo among various
tested  AAV  serotypes  [10,11,13-15].  A  careful  literature
survey revealed that the efficacy of numerous vectors has been
examined for corneal gene therapy but no efforts have been
made to study the role of vector-delivery techniques in corneal
gene transfer.
The stroma constitutes 90% of the corneal tissue and its
cellular  components  play  important  role  in  maintaining
corneal transparency, function and pathology. The stroma is
affected  in  a  variety  of  corneal  disorders  such  as  graft
rejection, haze, neovascularization, herpes keratitis, fibrosis
and scarring. Gene therapy treatments without any side effects
to treat stromal corneal disorders require localized expression
of therapeutic genes into keratocytes and/or the stroma. For
this purpose, numerous recombinant viruses and lipids were
tested administering variable volume, concentration, strength,
duration  and  frequency  of  vector  in  the  cornea  via
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2494microinjection, topical, electroporation, ultrasound or gene
gun [16]. Most of these studies are focused on identifying an
optimal vector and dose for delivering genes in the cornea in
vivo. To the best of our knowledge, no study harvested vector
delivery-techniques as a tool and studied its role for enhancing
and targeting gene delivery in the corneal stroma in vivo.
The hydration and porosity of the cornea regulate its
transparency [17]. The cornea constantly absorbs fluid from
the aqueous humor and limbal blood vessels and becomes
hazy if not pumped out by the endothelium [18]. The cadaver
human corneas are often hazy due to absorption of aqueous
humor but their transparency can be restored by incubating
tissue  in  warm  and  ventilated  chamber  at  31  °C  [19].
Furthermore, the drying of the cornea with a hair dryer is a
known conventional treatment for Fuchs’ dystrophy among
patients in eye clinic [20]. These observations prompted us to
hypothesize that controlled drying of the cornea with a defined
technique  will  deplete  water  content  and  increase  vector
absorption applied topically immediately on the dried cornea
without  jeopardizing  corneal  function.  The  present  study
tested this hypothesis using hair dryer, AAV8 vector and
topical application technique. Topical application is the most
acceptable method for delivering therapeutics in the eye. The
specific aims of the study were to evaluate whether controlled
drying of the cornea increases vector absorption in mouse and
rabbit  corneas  in  vivo  and  human  cornea  ex  vivo,  and
examined the effects of defined drying technique on gene
transfer, corneal structure and inflammatory reaction using an
in vivo mouse model.
METHODS
In vivo and ex vivo model: Six to eight week old female C57
mice (18–21 g) and New Zealand White rabbits (2.5–3.0 kg)
were  used  for  in  vivo  studies.  The  donor  human  corneas
procured from eye banks were used for ex vivo investigations.
All animals and human corneas were treated in accordance
with the tenets of the ARVO Statement for the Use of Animals
in Ophthalmic and Vision Research and the declaration of
Helsinki. Mice were anesthetized with intramuscular injection
of ketamine (130 mg/kg) and xylazine (8.8 mg/kg) whereas
rabbits  were  anesthetized  by  intramuscular  injection  of
ketamine  hydrochloride  (50  mg/kg)  and  xylazine
hydrochloride  (10  mg/kg).  Topical  ophthalmic  1%
proparacaine hydrochloride solution (Alcon, Ft. Worth, TX)
was instilled in each eye for local anesthesia.
Topical drying and vector delivery technique: The corneal
epithelium of the mouse and rabbit corneas was removed by
gentle scraping with a #64 Beaver blade (Becton–Dickinson,
Franklin Lakes, NJ) under an operating microscope under
general and local anesthesia. The epithelium of human cornea
was removed similarly after placing tissue on the dried surface
of the culture dish. After removing corneal epithelium eyes
were washed with BSS (Alcon) and wiped with a merocel
sponge. The Conair hair dryer of 234Watts (Model 1875;
Conair, Stamford, CT) was used for drying the rodent, rabbit,
and human corneas. The temperature and air-flow of warm air
were 41 °C and 6.8 m/s, respectively, according to digital
Velocicheck anemometer (Model 8330; TSI Inc., Shoreview,
MN). The hair dryer was operated from a distance of 8 inches
and approximately 45° angle to the eye. The corneas either
received no warm air (control) or warm air once for 10 s, twice
for 10 s with 5 s interval, or thrice for 10 s with 5 s interval
after every round or five times for 10 s with 5 s interval after
every round. Immediately after drying, 2 µl BSS or vector was
topically applied on the mouse cornea and 50 µl on the human
and  rabbit  corneas  for  two  min  using  a  custom-cloning
cylinder. The cloning cylinder of 3 mm diameter was used for
the  mouse  and  7  mm  diameter  for  the  rabbit  and  human
corneas.
Quantification of vector absorption: Hamilton microsyringes
(Hamilton,  Reno,  NV)  and  0.2-2ul  pipetman  (Gilson,
Middleton,  WI)  were  used  to  dispense  and  quantify
unabsorbed BSS or vector topically applied on the cornea
using a cloning cylinder. After 2 min, all unabsorbed BSS/
vector volume of the total 2 µl BSS/vector applied on the
mouse cornea (n=12) or 50 µl BSS applied on the rabbit
(n=12)  and  human  (n=12)  corneas  was  collected  and
measured. The amount of vector absorbed by the animal and
human  corneas  was  calculated  by  subtracting  unabsorbed
BSS/vector volume from the total applied BSS/vector volume.
The results are expressed in percent.
AAV vector production: AAV8 vector was generated using
adenovirus  free  system  following  methods  reported
previously [10]. Briefly, human embryonic kidney (HEK)
293cells  were  co-transfected  with  AAV2-based  genomic
vector pARAP4, AAV8 Rep/Cap plasmid, and adenovirus
helper plasmid in a ratio of 1:3:3. The pARAP4 expresses heat
stable  placental  alkaline  phosphatase  (AP)  under  the
regulation of Rous sarcoma virus (RSV) promoter/enhancer
and simian virus 40 (SV40) polyadenylation sequence. The
virus  containing  cell  lysate  was  harvested  at  62  h  post-
transfection. Recombinant viral stocks were purified by two
sequential  rounds  of  CsCl  gradient  ultracentrifugation.
Collected viral fractions were pooled and dialyzed through
two  rounds  of  HEPES-buffered  saline.  Viral  titer  was
determined by dot blot analysis using DIG labeled probes
(Roche  Applied  Science,  Indianapolis,  IN).  The  AAV
genomic plasmid (pARAP4) was obtained from Dr. Dusty
Miller, Fred Hutchison Cancer Research Center, Seattle WA
and  pAAV2/8  plasmid  was  procured  from  Dr.  James  M.
Wilson,  Gene  Therapy  Program,  Division  of  Medical
Genetics, University of Pennsylvania, Philadelphia PA.
AAV8 application to mouse cornea: Thirty-six female C57
mice were used to study the effects of drying the levels of gene
transfer. The study was approved by the Animal Care and Use
Committees  of  the  University  of  Missouri-Columbia  and
Harry S. Truman Memorial Veterans’ Hospital Columbia,
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2495MO. Mice were given general anesthesia with intramuscular
injection of ketamine and xylazine and local anesthesia by
instilling 1% proparacaine hydrochloride on the eye. After
removing epithelium, 2 µl BSS or AAV8 (1.1×108 genomic
copies/µl) was topically applied on mouse cornea for 2 min
using  a  custom-cloning  cylinder  (3  mm  in  diameter)  as
described earlier under vector delivery technique. The mice
were divided into 5 groups: Group-1 corneas received warm
air for 10 s, Group-2 corneas received 2 rounds of warm air
for 10 s with 5 s interval, Group-3 received 3 rounds of warm
air for 10 s with 5 s interval after every round, Group-4
received 5 rounds of warm air for 10 s with 5 s interval after
every round and Group-5 corneas did not receive any warm
air after merocel wiping and served as a control. All animals
were sacrificed at 14 days after BSS/vector application.
Tissue  embedding:  Mouse  eyes  were  enucleated  and
embedded  in  liquid  OCT  compound  (Sakura  FineTek,
Torrance, CA) within a 15 mm × 15 mm × 5 mm mold (Fisher
Scientific,  Pittsburgh,  PA)  and  snap  frozen  as  reported
previously [10]. The frozen tissue blocks were maintained at
−80 °C. Tissue sections (7 μ thick) were cut with a cryostat
(HM  525M;  Microm  GmbH,  Walldorf,  Germany)  and
maintained frozen at −80 °C until staining.
Tissue  morphology  and  gene  delivery:  Corneal  tissue
morphology was analyzed with hematoxylin and eosin (Fisher
Scientific)  staining  following  vendor’s  protocol.  The
delivered marker alkaline phosphatase (AP) gene expression
was  determined  with  cytochemical  staining  following
manufacturer’s  instructions.  In  brief,  tissue  sections  were
washed with HEPES buffer and incubated with a mixture of
5-bromo-4-chloro-3′-indolylphosphate  p-toluidine  (BCIP)
and nitro-blue tetrazolium (NBT) at 37 °C. The AP-stained
corneal  stroma  appeared  dark  blue.  Gene  transfer  was
quantified by determining the pixels of AP stained area in
400× magnification using National Institutes of Health Image
J 1.38X (NIH, Bethesda, MD) software.
Inflammatory  response:  The  effects  of  corneal  drying  on
inflammatory reaction were analyzed by the CD11b and F4/80
immunocytochemistry. The immunofluorescence staining for
CD11b (BD PharMingen, San Jose, CA) and F4/80 (Serotec,
Raleigh, NC) was performed using rat anti-mouse antibodies.
Tissue sections (7 µm) were washed with 1× HEPES, blocked
in  5%  BSA  for  30  min  followed  by  incubation  at  room
temperature with the primary antibody at 1:50 dilution for 90
min  and  with  secondary  antibody  goat  anti-rat  IgG
(AlexaFlour 594; Molecular Probes, Eugene, OR) at a dilution
of  1:500  for  60  min.  Vectashield  mounting  medium
containing DAPI (Vector Laboratories, Inc. Burlingame, CA)
was used to visualize nuclei in the tissue sections. The sections
were viewed and photographed under a Leica fluorescent
microscope  (Leica,  Wetzlar,  Germany)  equipped  with  a
digital camera.
Statistical  analysis:  The  results  were  expressed  as  mean
±standard error of the mean (SEM). Statistical analysis was
Figure 2. Effect of corneal drying on vector absorption in mice, rabbit
and human corneas. Corneas were subjected to zero (0 s), one (10 s),
two (20 s), three (30 s), or five (50 s) rounds of warm air drying and
2 µl (mouse) or 50 µl (rabbit and human) of vector/BSS was applied
onto corneas for 2 min immediately after drying. The amount of
vector  absorbed  by  the  corneas  was  calculated  by  subtracting
unabsorbed BSS/vector volume from the total applied BSS/vector
volume.  The  results  are  expressed  in  percent  as  mean±SEM
*p<0.001 as compared to 0 s or 10 s; ψp<0.001 as compared to 20 s.
Figure 1. Representative image showing newly-defined vector application technique using cloning cylinder. A: Mouse cornea, in vivo. B:
Rabbit cornea, in vivo. C: Human cornea, ex vivo.
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2496performed  using  either  one-way  ANOVA  (ANOVA)
followed by Tukey’s multiple comparison test or two-way
ANOVA followed by Bonferroni test.
RESULTS
Topical vector delivery technique: Figure 1 shows details of
the  defined  vector  application  technique  developed  for
controlled and targeted gene delivery in the stroma, in vivo.
As evident from figure, dispensing of BSS/vector inside a
cloning cylinder limits its contact to neighboring ocular tissue.
This  significantly  enhanced  transgene  delivery  into  the
targeted corneal stroma and prevented transgene delivery into
untargeted tissues such as limbus, conjunctiva, sclera, etc.
Effect of corneal drying on absorption of topically applied
solution:  Figure  2  shows  the  effect  of  corneal  drying  on
absorption of topically applied BSS solution in mouse, rabbit,
and human corneas. Mice corneas subjected to 0 or 10 s drying
showed 8±1.5% absorption of topically applied BSS solution.
Drying for 20, 30, or 50 s significantly (p<0.001) enhanced
the  absorption  to  21±1.4%,  19±2.1%,  and  25±1.5%,
respectively. No statistical significance in corneal absorption
was noted between 20, 30, or 50 s of drying, which may be
because of small volume (2 µl) of topically applied solution.
Zero and 10 s drying of rabbit corneas showed 7±1.1%
absorption of topically applied BSS solution. Twenty seconds
of warm air drying significantly (p<0.001) enhanced corneal
absorption to 14±0.8%. Thirty and 50 s of warm air drying in
rabbits resulted in further increase in corneal absorption to
22±0.6% and 27±0.8% (p<0.001; Figure 2).
Human corneas exposed to 0 or 10 s of drying showed
7±0.6% absorption of topically applied BSS solution. Twenty
seconds of warm air drying enhanced corneal absorption to
10±0.6% but the increase was not statistically significant.
Corneas subjected to 30 or 50 s of drying showed 19±1.15%
and 24±0.9% absorption which was significantly (p<0.001)
more compared to corneas subjected to either zero or twenty
cycles of air drying (Figure 2).
Effect of corneal drying on gene expression: We next tested
the effect of different rounds of corneal drying on AAV-
Figure 3. Representative images showing alkaline phosphatase marker gene delivery (purple) detected on day in control (naive) and 
$$9treated mouse cornea in vivo that received warm air. A: Naive. B: 20 s. C: 30 s. D: 50 s. Scale bar denotes 50 µm.
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2497mediated gene expression. Figure 3 shows AAV8-mediated
gene expression in mice corneas subjected to 20, 30, or 50 s
drying. Corneas exposed to 20 or fewer seconds of drying
showed mild to moderate level of gene expression. As is
evident from the figure, corneas exposed to 30 s of drying
demonstrated  significantly  more  gene  expression.  Fifty
seconds of drying resulted in a further enhancement of gene
expression (Figure 3).
Figure 4 shows the quantification of gene expression in
corneas subjected to 20, 30, or 50 s of warm air drying.
Corneas exposed to 50 s of drying showed the highest level
of gene expression and it was significantly (p<0.05) more
compared  to  groups  subjected  to  20  and  30  s  of  drying.
Relative comparison between the 30 s and 20 s treatment
group revealed significantly (p<0.05) higher levels of gene
expression in corneas exposed to 30 s of drying.
Effect  of  corneal  drying  on  corneal  morphology  and
inflammatory  response:  To  test  the  possibility  of  corneal
injury due to warm air drying, we performed histological
examination  by  hematoxylin  and  eosin-staining  of  mice
corneas.  Figure  5  shows  hematoxylin  and  eosin-stained
corneal sections obtained from mice subjected to 0, 20, 30, or
50 s of warm air drying. No apparent structural abnormalities
were detected in mice corneas subjected to 30 or fewer s of
warm air drying. On the other hand, mice corneas exposed to
50 s of warm air drying showed structural damage in the
anterior  stroma.  A  large  number  of  hematoxylin-stained
nuclei  were  also  detected  in  the  anterior  stroma  of  these
corneas suggesting the possibility of inflammatory cells.
Figure 4. Digital quantification of delivered marker gene expression
detected at day 14 in mouse corneas in vivo. These corneas received
2 µl of AAV8 vector immediately after 0, 20, 30, or 50 s of drying.
The corneas that underwent 50 s of drying showed the highest level
of gene expression followed by 30 s and then the 20 s group. *p<0.05
as compared to 20 s; ψp<0.05 as compared to 30 s.
The presence of inflammatory cells was confirmed by
imunostaining  for  CD11b,  a  marker  for  activated
granulocytes,  and  F4/80,  a  macrophage  specific  antigen.
Figure 6 shows CD11b staining in corneas exposed to 0, 20,
30, or 50 s of warm air drying. Mice corneas subjected to ±30
s of warm air showed 7±2 CD11b+ cells and 50 s showed 33±5
CD11b+ cells, suggesting increase infiltration of activated
granulocytes in severely dried cornea. The F4/80, marker for
macrophages, showed similar results (data not shown).
DISCUSSION
Recent success in vision restoration in patients suffering with
Leber  congenital  amaurosis  with  gene  therapy  affirms  its
promise  to  treat  eye  diseases  [21,22].  Gene  therapy
approaches for corneal diseases is still in a developmental
phase in which practical considerations for safety and efficacy
have dominated the efforts. Numerous viral and non-viral
vectors  have  been  identified  for  this  purpose  [5-7].  Our
laboratory  recently  studied  the  efficacy  and  toxicity  of
multiple AAV serotypes for delivering genes in the stroma
using in vitro [9,11] and in vivo [10,13] models. To reduce
side effects, improve safety and augment targeted delivery of
genes into keratocytes or the stroma in vivo with AAV we are
attempting  to  define  vector-delivery  techniques.  It  is  our
central hypothesis that vector and vector-delivery techniques
regulate transgene delivery in the cornea in vivo. In this study,
we  report  a  simple  minimally  invasive  hair-dryer  based
topical vector-delivery technique that significantly increases
AAV-mediated transgene delivery in the mouse stroma in
vivo, without compromising typical corneal morphology or
function. Furthermore, we report that controlled drying of the
mouse, rabbit and human corneas with hair dryer increases
vector absorption in these tissues, and likely is the reason for
increased transgene delivery in the mouse stroma in vivo.
Corneal  hydration  is  regulated  by  epithelial  barrier,
proteoglycans’  water  holding  capacity,  endothelial  water-
pumping mechanism, intraocular pressure and evaporation of
fluid  from  the  corneal  surface  and  is  critical  for  corneal
function and clear vision [23,24]. In addition to these factors
many agents such as benzalkonium chloride, cetylpyridinium
chloride,  EDTA,  polyethoxylated  castor  oil,  sodium
deoxycholate etc present in ophthalmic topical formulations
have been shown to influence corneal hydration [23,25]. We
postulated  that  controlled  drying  of  the  cornea  for  short
duration augments fluid absorbing capacity of the cornea until
corneal  hydration  returns  to  the  normal  levels.  Indeed,
increased uptake of topical solution after corneal drying was
observed in mouse, rabbit, and human corneas. Based on these
observations,  we  conclude  that  enhanced  transgene
expression noted in mouse cornea in vivo after the topical
application  of  AAV  vector  on  de-epitheliazed  air-dried
corneas  is  because  of  increased  vector  absorption.  The
hairdryer-assisted corneal drying was chosen because this
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practice for corneal abnormalities such as Fuchs’ dystrophy
[20]. We observed that application of 5 rounds of 10 s air
drying  compromised  corneal  morphology  in  vivo  and  3
rounds of 10 s drying significantly augmented gene transfer
without jeopardizing corneal morphology and 1 or 2 rounds
of 10 s drying augmented only mild-to-moderate degree of
gene  transfer  with  no  altered  corneal  morphology.  These
observations suggest that identification of duration of corneal
drying for each species may be required.
Corneal epithelium acts as a strong barrier to topical gene
delivery. We found that removal of corneal epithelium is
necessary for achieving larger and targeted gene delivery into
the stroma of mouse and rabbit corneas in vivo [8,10,13]. In
the present study, the epithelium was removed via mechanical
scraping  as  this  technique  is  routinely  used  clinically  in
refractive laser surgical procedures such as photorefractive
keratectomy, laser epithelial keratomileusis, etc. Mechanical
removal  of  epithelium  is  known  to  induce  keratocyte
apoptosis, inflammation and wound healing in the cornea
[26,27]. We [26,27] and other researchers [28] have shown
that  release  of  cytokines  and  growth  factors  following
epithelial injury that ignite a transient wound healing response
in  the  cornea.  No  additional  inflammatory  response  was
Figure 5. Representative images of H&E staining showing histology of mouse corneas subjected to air drying and collected on day 14 after
vector application. A: Naive. B: 20 s. C: 30 s. D: 50 s. Corneas exposed to ≤30 s of drying showed normal morphology whereas corneas
subjected to 50 s of drying showed moderate morphological changes in anterior stroma. Scale bar denotes 50 µm.
Figure 6. Representative immunohistochemistry images showing CD11b+ cells in naive and AAV-treated mouse corneas subjected to warm
air and collected on day 14 after vector application. A: Naive. B: 20 s. C: 30 s. D: 50 s. DAPI stained nuclei are shown in blue and CD11b+
cells are shown in red. Scale bar denotes 50 µm.
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drying  as  supported  by  the  detection  of  statistically
comparable level of inflammatory cells in mouse corneas
exposed  to  zero  or  3  rounds  of  ten  seconds  drying.
Significantly  more  inflammatory  cells  were  noted  in  the
corneal sections receiving 5 rounds of 10 s drying.
In conclusion, we demonstrate that controlled drying of
the cornea with hair dryer is safe and results in increased
vector  absorption  and  consequently  enhanced  transgene
delivery  in  the  cornea.  Furthermore,  the  newly  optimized
minimally invasive topical vector-delivery technique can be
used in combination with AAV vector to achieve therapeutic
levels of genes in the stroma of the cornea in vivo without
causing significant side effects.
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